Cinnamon is one of the most popular kitchen-spice remedies for blood sugar — but the evidence is more mixed than the headlines suggest. We break down how cinnamon affects insulin sensitivity, the critical difference between Ceylon and Cassia (and the coumarin liver risk), what meta-analyses actually found, safe dosing, and how to read cinnamon claims on supplement labels.
Last updated: June 14, 2026 · Edited by BloodSugarLab Editorial Team · See methodology
The Basics
Cinnamon is a spice made from the inner bark of trees in the Cinnamomum genus. It has been used in traditional medicine for centuries, and modern research has explored whether its bioactive compounds can help moderate blood sugar. But there is a crucial distinction most people miss: not all cinnamon is the same, and the difference matters for both effectiveness and safety.
There are two main commercial types of cinnamon, and they are botanically different plants. Ceylon cinnamon (Cinnamomum verum, literally "true cinnamon") comes mainly from Sri Lanka and has a delicate, mild flavor and soft, layered bark. Cassia cinnamon (typically Cinnamomum cassia or C. aromaticum) is the cheaper, more pungent variety that fills most grocery-store spice jars and bakery products in North America. Unless a label specifically says "Ceylon," the cinnamon you have is almost certainly Cassia.
This distinction is not just about taste. Cassia cinnamon contains far higher levels of a natural compound called coumarin, which can be toxic to the liver in high enough amounts. At the same time, most of the blood-sugar research has actually been done on Cassia — so you are caught between the form that has been studied more and the form that is safer to take in larger doses. We unpack that tension in detail below.
Why this matters: Cinnamon is genuinely interesting for blood sugar, but it is not in the same evidence tier as berberine or chromium. Meta-analyses show it can lower fasting glucose, yet effects on long-term markers like HbA1c are inconsistent across studies. Treat cinnamon as a modest, supportive ingredient — and pay close attention to which type you are using.
The Mechanism
Cinnamon does not lower blood sugar the way a prescription medication does. Researchers have proposed several overlapping mechanisms by which its bioactive compounds — including cinnamaldehyde and certain water-soluble polyphenols — may influence glucose metabolism. The evidence for these pathways comes largely from laboratory and animal studies, with human data being more variable.
The most studied mechanism is improved insulin signaling. Cinnamon polyphenols have been shown in cell and animal models to enhance insulin receptor activity and increase glucose uptake into cells. By making cells more responsive to the insulin already circulating, cinnamon may help move glucose out of the bloodstream more efficiently — conceptually similar to how chromium works, though through different compounds.
Some research suggests cinnamon slows the rate at which the stomach empties after a meal. By delaying how quickly food — and therefore glucose — enters the small intestine, cinnamon may blunt the post-meal blood sugar spike. This is one reason cinnamon is often studied in the context of glucose tolerance tests rather than fasting levels alone.
Laboratory studies indicate cinnamon extracts can inhibit alpha-glucosidase and alpha-amylase, the digestive enzymes that break complex carbohydrates down into absorbable sugars. Slowing this breakdown reduces how rapidly glucose is released into the blood after a carbohydrate-rich meal — a mechanism shared with certain diabetes medications, though cinnamon's effect is far milder.
Cinnamon is rich in polyphenol antioxidants. Because chronic oxidative stress and low-grade inflammation are intertwined with insulin resistance, cinnamon's antioxidant capacity may contribute indirectly to better metabolic health. This is a plausible supporting mechanism rather than a primary driver of glucose lowering.
The key caveat is that mechanism and clinical outcome are not the same thing. Cinnamon clearly does something to glucose metabolism in the lab, but translating that into consistent, meaningful improvements in real people has proven harder — which is exactly what the clinical evidence below shows.
The Evidence
Cinnamon has been studied in dozens of human trials and several meta-analyses. The honest summary is that the results are mixed — fasting glucose tends to improve, but the picture for HbA1c is far less consistent. Here are the findings most often cited in the literature.
Published in Diabetes Care, this often-cited trial from Pakistan gave 60 people with Type 2 diabetes Cassia cinnamon at 1g, 3g, or 6g per day, or placebo, for 40 days.
Results: All three cinnamon doses were reported to reduce fasting glucose, as well as triglycerides and total cholesterol, compared with placebo — with no clear dose-response pattern. This study generated enormous interest and is largely responsible for cinnamon's reputation as a blood sugar aid.
Significance & caveats: It was a small, short trial in a specific population, and later studies struggled to reproduce results of the same magnitude. It is best read as the hypothesis-generating starting point, not as definitive proof.
This systematic review and meta-analysis pooled 10 randomized controlled trials of cinnamon in people with Type 1 or Type 2 diabetes.
Results: Cinnamon was associated with a statistically significant reduction in fasting plasma glucose, along with improvements in some lipid markers. Crucially, however, the analysis found no significant effect on HbA1c — the gold-standard measure of longer-term blood sugar control.
Significance: This is the central honest finding in the cinnamon literature: a short-term fasting-glucose signal that does not reliably translate into improved long-term glycemic control.
Published by the Cochrane Collaboration, widely regarded as the most rigorous standard for evidence synthesis, this review examined cinnamon for diabetes across 10 randomized trials involving over 500 participants.
Results: The authors concluded there was insufficient evidence to support the use of cinnamon for Type 1 or Type 2 diabetes, citing inconsistent results, methodological limitations, and a lack of impact on HbA1c. This sober assessment is an important counterweight to more enthusiastic single studies.
Several subsequent meta-analyses pooled additional trials, including studies of standardized aqueous cinnamon extracts.
Results: These analyses generally reported modest reductions in fasting glucose — on the order of a small but measurable drop — with some also suggesting a small HbA1c benefit, while others did not. The disagreement between meta-analyses, driven by which trials are included and how cinnamon type and dose vary, is itself the headline: the effect, where present, is small and not uniformly replicated.
What the evidence honestly tells us: Cinnamon shows a fairly consistent ability to nudge fasting glucose downward in the short term, but its effect on HbA1c — the marker that reflects real long-term control — is inconsistent, and respected reviews like Cochrane have judged the overall evidence insufficient. This is meaningfully weaker and more mixed than the evidence base for berberine or chromium. Cinnamon is best viewed as a low-cost, modest helper, not a primary intervention, and it is no substitute for medication, diet, or your doctor's guidance.
Practical Guidance
If you decide to try cinnamon, the form and dose matter more here than with almost any other blood sugar ingredient — because the cheaper, more-studied type carries a real liver-toxicity risk at higher daily amounts. Read this section carefully.
Human trials have used a fairly wide range of doses depending on the form of cinnamon:
This is the range used in many trials, including Khan (2003). It is also the range where coumarin intake becomes a genuine concern with Cassia. The higher end of this range, taken daily and long-term, can push coumarin intake well past recommended safety limits for many adults.
Water-soluble extracts (such as the patented Cinnulin PF) concentrate the polyphenols thought to be active while leaving behind most of the fat-soluble coumarin. Studies have used much smaller milligram doses of these extracts, which is part of their appeal for daily use.
Because Ceylon ("true") cinnamon contains only trace coumarin, larger daily amounts can be taken with far less hepatotoxicity concern. The trade-off is that fewer blood-sugar trials have used Ceylon specifically, so its glucose benefit is less directly documented.
Coumarin is a naturally occurring aromatic compound. In sufficient quantities it can cause liver damage in sensitive individuals, and European food-safety authorities set a tolerable daily intake of roughly 0.1 mg of coumarin per kilogram of body weight. The amount of coumarin in cinnamon depends almost entirely on the type:
Cassia can contain on the order of several thousand parts per million of coumarin (commonly cited figures range up to around 5–7 mg of coumarin per gram of cinnamon, though it varies by source). At these levels, a daily teaspoon or two of Cassia can approach or exceed the tolerable intake for a smaller adult — which is why daily high-dose Cassia for blood sugar is a real liver-safety issue, not a theoretical one.
Ceylon ("true") cinnamon contains only trace amounts of coumarin — typically a tiny fraction of what Cassia contains. For anyone planning to take cinnamon daily over months, Ceylon is the substantially safer choice, even though it costs more and is harder to find. If a product does not clearly state "Ceylon," assume it is Cassia.
Aqueous (water-based) extraction pulls out the polyphenols believed to drive cinnamon's metabolic effects while leaving most of the fat-soluble coumarin behind. Branded extracts like Cinnulin PF were developed partly for this reason. These extracts let manufacturers deliver a studied, standardized polyphenol dose without the coumarin load of whole-bark Cassia.
Practical rule of thumb: For daily, long-term use, choose Ceylon cinnamon or a standardized water-soluble extract rather than large doses of ground Cassia. If you use Cassia, keep it modest (the kind of amount you would use in cooking), and do not take grams of it every day for months without talking to your doctor — especially if you have any liver concerns.
Supplement Analysis
Cinnamon is a popular ingredient in blood sugar formulas because it is familiar, inexpensive, and has a positive (if overstated) public reputation. But the quality of how it is used varies enormously. Here is how to separate a thoughtful formula from a marketing gimmick.
GlucoTrust, our top-rated blood sugar supplement overall, takes the multi-ingredient approach we prefer — combining several research-backed compounds rather than leaning on any single spice. We favor this strategy precisely because individual ingredients like cinnamon have modest, mixed evidence on their own; layering complementary compounds addresses blood sugar through several pathways at once. Learn more about GlucoTrust here.
Want a blood sugar supplement that combines cinnamon-style support with better-evidenced ingredients and transparent dosing? We've tested 14 formulas and identified the top 3.
See Our Top 3 Recommended SupplementsSafety
In culinary amounts, cinnamon is safe for most people. The safety concerns appear at the higher, daily, supplemental doses used for blood sugar — and they center on coumarin, the liver, and interactions with diabetes medications.
For most people, cinnamon is well tolerated. Reported issues include:
The most important safety consideration with cinnamon — specifically Cassia — is coumarin-related liver toxicity. People with existing liver disease, or those taking other medications that stress the liver, should be especially cautious with daily high-dose Cassia. Choosing Ceylon cinnamon or a low-coumarin standardized extract largely sidesteps this concern.
Bottom line on safety: Cinnamon as a spice is safe; cinnamon as a daily high-dose supplement requires more care. The main risks are coumarin-related liver toxicity from Cassia and additive glucose lowering with diabetes medication. Choose Ceylon or a standardized low-coumarin extract, keep doses reasonable, and consult your healthcare provider — this article is educational information, not medical advice.
Common Questions
The evidence is mixed. Multiple meta-analyses, including Allen et al. (2013), have found that cinnamon can produce a modest reduction in fasting blood glucose in the short term. However, its effect on HbA1c — the marker of long-term control — is inconsistent, and a respected Cochrane review concluded there was insufficient evidence to recommend cinnamon for diabetes. Cinnamon may offer a small supportive benefit, but it is not a reliable standalone treatment and does not replace medication or medical care.
Cassia is the common, inexpensive grocery-store cinnamon and is the type used in most blood-sugar studies — but it is high in coumarin, a compound that can harm the liver at high daily doses. Ceylon ("true") cinnamon contains only trace coumarin, making it much safer for daily, long-term use, though it has been studied less directly for glucose. For ongoing supplementation, Ceylon or a standardized low-coumarin extract is the safer choice.
Trials have used roughly 1–6 grams per day of ground Cassia, or much smaller doses (around 120–500 mg) of standardized water-soluble extracts such as Cinnulin PF. The catch is that high daily Cassia at the upper end can exceed safe coumarin limits. If you want to try cinnamon daily, favor Ceylon or a standardized extract, start modest, and check with your doctor first — particularly if you take diabetes medication or have liver concerns.
No. Both chromium and especially berberine have a stronger and more consistent body of clinical evidence for improving glucose markers than cinnamon does. Cinnamon's data are more mixed, with a short-term fasting-glucose signal but unreliable HbA1c effects. That is why we view cinnamon as a modest, complementary ingredient best used within a multi-ingredient formula such as GlucoTrust rather than as a primary blood sugar strategy on its own.
Cinnamon is a low-cost, mildly supportive ingredient, but the research is mixed and it addresses only part of the picture. The most consistent results in blood sugar supplements come from multi-ingredient formulas that combine cinnamon-style support with better-evidenced compounds like chromium, berberine, and Gymnema — with transparent dosing and a focus on safety.
See Our Top 3 Blood Sugar Supplements for 2026All recommended products include 60-day money-back guarantees
Keep Learning